Lv4
430 积分 2025-04-23 加入
Glypican-1-targeted antibody-drug conjugate shows therapeutic efficacy in lung squamous cell carcinoma
9天前
已关闭
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
10天前
已完结
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
11天前
已关闭
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
15天前
已关闭
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
22天前
已完结
Tumor-Associated Carbohydrate Antigens (TACA) as Novel Targets for Anticancer Therapy
1个月前
已完结
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
1个月前
已完结
Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer
1个月前
已完结
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
1个月前
已完结
ADME investigations of novel therapeutic modalities: challenges and opportunities 2025
1个月前
已完结
皖公网安备34019202002308
